Bank Of New York Mellon Corp Entrada Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$9.58 - $16.2 $119,165 - $201,511	12,439 New	12,439 $180 Million
Q4 2022 Feb 14, 2023	BUY	$13.52 - $22.89 $168,175 - $284,728	12,439 New	12,439 $168,000
Q2 2022 Aug 15, 2022	SELL	$5.49 - $12.94 $120,412 - $283,813	-21,933 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$7.99 - $16.93 $66,125 - $140,112	8,276 Added 60.6%	21,933 $206,000
Q4 2021 Feb 11, 2022	BUY	$13.7 - $35.0 $187,100 - $477,995	13,657 New	13,657 $234,000

101

28.1M

34.5K

16.4K

Ticker TRDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,368,500
Market Cap $551M
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.